2771 - 2780 of 8823 Results
Title
Year
-
OPENTitle: Gastric acid suppressants and cognitive decline in people with or without cognitive impairmentJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page: e12243End Page: e12243Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12243Best OA location URL: https://doi.org/10.1002/trc2.12243Citation Count: 13
-
OPENTitle: Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL‐AD preclinical testing core studyJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page: e12329End Page: e12329Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12329Best OA location URL: https://doi.org/10.1002/trc2.12329Citation Count: 17
-
OPENTitle: Low dose DMSO treatment induces oligomerization and accelerates aggregation of α-synucleinJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page: 3737End Page: 3737Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-022-07706-2Best OA location URL: https://www.nature.com/articles/s41598-022-07706-2.pdfCitation Count: 17
-
OPENTitle: Proceedings of Reanimation 2021, the French Intensive Care Society International CongressJournal Name: Annals of Intensive CarePublisher: Springer Science and Business Media LLCVol: 11Issue #: S1Start Page: 97End Page: 97Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13613-021-00862-0Best OA location URL: https://annalsofintensivecare.springeropen.com/track/pdf/10.1186/s13613-021-00862-0Citation Count: 6
-
OPENTitle: Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III StudiesJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 35Issue #: 7Start Page: 781End Page: 794Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40263-021-00826-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40263-021-00826-9.pdfCitation Count: 22
-
OPENTitle: 28th Annual Meeting of the Dysphagia Research SocietyJournal Name: DysphagiaPublisher: Springer Science and Business Media LLCVol: 36Issue #: 6Start Page: 1118End Page: 1184Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00455-020-10221-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00455-020-10221-z.pdfCitation Count: 4
- Neuropathological correlation supports automated image-based differential diagnosis in parkinsonism2021OPENTitle: Neuropathological correlation supports automated image-based differential diagnosis in parkinsonismJournal Name: European Journal of Nuclear Medicine and Molecular ImagingPublisher: Springer Science and Business Media LLCVol: 48Issue #: 11Start Page: 3522End Page: 3529Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00259-021-05302-6Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8440366Citation Count: 20
-
OPENTitle: Striatal ΔFosB gene suppression inhibits the development of abnormal involuntary movements induced by L-Dopa in ratsJournal Name: Gene TherapyPublisher: Springer Science and Business Media LLCVol: 28Issue #: 12Start Page: 760End Page: 770Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41434-021-00249-7Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8433270Citation Count: 15
-
OPENTitle: Response to Telemedicine Visits From Patients With Parkinsonism During the COVID-19 Pandemic on Postvisit SurveysJournal Name: Journal of Patient ExperiencePublisher: SAGE PublicationsVol: 8Issue #:Start Page: 2374373521997224End Page: 2374373521997224Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/2374373521997224Best OA location URL: https://doi.org/10.1177/2374373521997224Citation Count: 14
-
OPENTitle: Parkinson’s Patients’ Tolerance for Risk and Willingness to Wait for Potential Benefits of Novel Neurostimulation Devices: A Patient-Centered Threshold Technique StudyJournal Name: MDM Policy & PracticePublisher: SAGE PublicationsVol: 6Issue #: 1Start Page: 2381468320978407End Page: 2381468320978407Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/2381468320978407Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/2381468320978407Citation Count: 23